Jaguar Health (JAGX) News Today → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free JAGX Stock Alerts $0.26 -0.03 (-10.40%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 5:32 AM | americanbankingnews.comJaguar Health (NASDAQ:JAGX) Share Price Passes Above 50-Day Moving Average of $0.15May 16 at 3:30 AM | americanbankingnews.comJaguar Health (NASDAQ:JAGX) Coverage Initiated at StockNews.comMay 16 at 3:30 AM | marketbeat.comStockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX)StockNews.com initiated coverage on shares of Jaguar Health in a research note on Thursday. They set a "sell" rating on the stock.May 15, 2024 | finance.yahoo.comJaguar Health Inc (JAGX) Q1 2024 Earnings Call Transcript Highlights: Strategic Expansions and ...May 14, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports First Quarter 2024 Financial ResultsMay 14, 2024 | msn.comJAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | msn.comJaguar Health Q1 2024 Earnings PreviewMay 10, 2024 | benzinga.comLatest News for Jaguar Health Stock (NASDAQ:JAGX)May 10, 2024 | benzinga.comPeering Into Jaguar Health's Recent Short InterestMay 7, 2024 | investorplace.comWant $10,000? Invest $1,000 in These 3 Penny Stocks NowMay 6, 2024 | finance.yahoo.comCrofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational New Animal Drug Application for the Indication of General Diarrhea in DogsApril 17, 2024 | msn.comWhy Jaguar Health Stock Is Up TodayApril 17, 2024 | markets.businessinsider.comGold Moves Higher; Morgan Stanley Earnings Top ViewsApril 16, 2024 | investorplace.comWhy Is Jaguar Health (JAGX) Stock Up 44% Today?April 10, 2024 | benzinga.comS&P 500 Down 1%; Delta Air Lines Posts Upbeat EarningsApril 10, 2024 | msn.comJaguar Health shareholders approve reverse stock splitApril 10, 2024 | investorplace.comWhat Is Going on With Jaguar Health (JAGX) Stock Today?April 10, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of StockholdersApril 9, 2024 | msn.comWhy Jaguar Health Stock Is Soaring After-HoursApril 3, 2024 | finance.yahoo.comJaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)April 2, 2024 | finance.yahoo.comJaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call TranscriptApril 1, 2024 | investorplace.comJAGX Stock Earnings: Jaguar Health Misses Revenue for Q4 2023April 1, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports 2023 Financial ResultsMarch 31, 2024 | markets.businessinsider.comWhat Wall Street expects from Jaguar Health's earningsMarch 20, 2024 | edition.cnn.comJaguar Health, Inc.March 20, 2024 | finance.yahoo.comGEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to MarketMarch 15, 2024 | finance.yahoo.comCapricor Therapeutics, Inc. (4LN2.F)March 1, 2024 | msn.comWhat In The World Is Going On With Jaguar Health (JAGX) Stock?February 23, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Requests and Receives Hearing on Nasdaq Listing ComplianceFebruary 17, 2024 | money.usnews.comJaguar Health IncFebruary 15, 2024 | finance.yahoo.comJaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in DogsFebruary 14, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct ReliefFebruary 14, 2024 | finance.yahoo.comJaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct ReliefFebruary 12, 2024 | ca.finance.yahoo.comJaguar Health, Inc. (JAGX)February 12, 2024 | finance.yahoo.comJaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related DiarrheaJanuary 31, 2024 | investing.comJaguar Health Inc (JAGX)January 30, 2024 | msn.com'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health ChallengesJanuary 30, 2024 | finance.yahoo.comMagdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical RegionsJanuary 29, 2024 | finance.yahoo.comJaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select ConferenceJanuary 25, 2024 | finance.yahoo.comDog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)January 22, 2024 | finance.yahoo.comJaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)January 4, 2024 | finance.yahoo.comIssuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)December 18, 2023 | finance.yahoo.comJaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 61%December 11, 2023 | finance.yahoo.comA Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage IIDecember 8, 2023 | morningstar.comJaguar Health Inc JAGXDecember 7, 2023 | finance.yahoo.comMASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family CompanyDecember 6, 2023 | finance.yahoo.comStudy Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) WebsiteDecember 4, 2023 | msn.comFDA renews conditional approval for Jaguar canine chemo drugDecember 4, 2023 | finance.yahoo.comFDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in DogsNovember 30, 2023 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. JAGX Media Mentions By Week JAGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAGX News Sentiment▼0.140.42▲Average Medical News Sentiment JAGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAGX Articles This Week▼82▲JAGX Articles Average Week Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRVS News HOOK News CNTB News LFVN News TPST News AFMD News LPTX News MRNS News RVPH News ANEB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAGX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport Society41 banks launch ‘crypto dollar’Stansberry ResearchWhat’s Really Next for America…Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
